High molecular weight kininogen (NK) attaches to endothelial cells by separ
ate sites on the heavy and light chains and requires 15-50 mu M zinc. Previ
ously identified binding proteins include gC1qR, cytokeratin 1, and the uro
kinase plasminogen activator receptor; however, their relative contribution
s to binding are not yet clarified. We have prepared affinity columns to wh
ich were coupled either cleaved HK or peptide LDCNAEVYVVPWEKKIYPTVNCQPLMGM
derived from heavy-chain domain 3. Endothelial cell membranes were solubili
zed and chromatographed in the presence or absence of zinc ion, the bound p
roteins were eluted, and active fractions were identified by dot blot using
biotinylated HK, SDS/PAGE, and Western blot analysis. The peptide containi
ng column eluate revealed but one band at 68 kDa if zinc ion was present wh
ich was identified as cytokeratin 1 by amino acid sequencing of an internal
peptide, The HK affinity column revealed bands at 68 kDa (cytokeratin 1),
33 kDa (gC1qR), and 66 kDa (unidentified). HK or domain 3-derived peptide b
ound to the 68 kDa band; prekallikrein and Factor XII did not. HK or Factor
XII bound to the 33-kDa band if zinc was present while no binding to the 6
6 kDa band was observed. Antibody to cytokeratin 1 inhibited HK binding to
endothelial cells by 30%, antibody to gC1qR inhibited RR binding to endothe
lial cells by 72%, and a mixture of both inhibited binding by 86%. Our data
suggest HK binding by interaction of the heavy-chain domain 3 with cytoker
atin 1 and the light chain with gC1qR. (C) 1999 Academic Press .